Skip to main content
TARA
NASDAQ Life Sciences

Wiseek Filing Insight

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
4
Price
$5.06
Mkt Cap
$273.667M
52W Low
$2.77
52W High
$7.82
Market data snapshot near publication time

check_boxKey Events

  • No key events were highlighted for this filing.

auto_awesomeAnalysis

No analysis available.

At the time of this filing, TARA was trading at $5.06 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $273.7M. The 52-week trading range was $2.77 to $7.82. This filing was assessed with an importance score of 4 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed TARA - Latest Insights

TARA
Apr 23, 2026, 8:42 PM EDT
Filing Type: 144
Importance Score:
7
Baker Brothers Life Sciences Files Intent to Sell Over $1.6M in Protara Therapeutics Stock
Sentiment: Negative
View Wiseek Article
TARA
Apr 23, 2026, 8:41 PM EDT
Filing Type: 144
Importance Score:
7
Major Institutional Investor Files Intent to Sell Over $1.7M in Protara Therapeutics Stock
Sentiment: Negative
View Wiseek Article
TARA
Apr 17, 2026, 4:15 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Shareholders to Vote on Doubling Authorized Shares and Expanding Equity Plan, Signaling Substantial Future Dilution
Sentiment: Negative
View Wiseek Article
TARA
Mar 10, 2026, 8:11 AM EDT
Filing Type: 10-K
Importance Score:
8
Annual Report Confirms Key FDA Designations & Phase 3 Trial Initiation, Bolstering Pipeline Amidst Dilution
Sentiment: Positive
View Wiseek Article
TARA
Mar 10, 2026, 8:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Protara Therapeutics Secures $198M Cash Runway into 2028, Reports Positive Clinical Progress
Sentiment: Positive
View Wiseek Article
TARA
Mar 10, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Protara Gains Breakthrough Therapy for TARA-002, Boosts Cash to $198M with Oversubscribed $86M Offering
Sentiment: Positive
View Wiseek Article
TARA
Mar 06, 2026, 5:51 PM EST
Filing Type: 144
Importance Score:
7
Institutional Investor 667, L.P. Files Intent to Sell Shares, Part of Larger Baker Brothers Group Liquidation
Sentiment: Negative
View Wiseek Article
TARA
Mar 06, 2026, 5:50 PM EST
Filing Type: 144
Importance Score:
7
Baker Brothers Life Sciences Files Intent to Sell $2.7M in Protara Therapeutics Shares
Sentiment: Negative
View Wiseek Article
TARA
Mar 06, 2026, 4:15 PM EST
Filing Type: 424B7
Importance Score:
7
Prospectus Supplement Adds New Selling Stockholders for 400,000 Warrant Shares Resale
Sentiment: Negative
View Wiseek Article
TARA
Mar 04, 2026, 8:37 PM EST
Filing Type: 144
Importance Score:
7
Baker Brothers Affiliate Files Intent to Sell $220K in Protara Therapeutics Shares Amid Coordinated Disposition
Sentiment: Negative
View Wiseek Article